Biotechnology production factory

Located in Switzerland, this production site manufactures three medicines designed to treat two types of blood‑clotting disorders or deficiencies.

In constant evolution since 1996, it continues to expand with the construction of a new building dedicated to vial filling.

This new facility integrates seamlessly into the existing site, echoing its defining architectural principles: simple, white volumes with clean, refined lines.

Organised over three levels, the building is clad with façades made of pre‑industrialised glass elements. The process areas feature transparent façades, providing visual comfort for the teams, while the technical areas are concealed behind white‑tinted glass.

The use of these pre‑industrialised panels enables rapid, element‑by‑element installation while ensuring partial removability. This feature gives the building genuine capacity for future evolution, facilitating the introduction of large‑scale process equipment or potential extensions of the facility.